These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 39116118)

  • 1. Elucidating the inhibitory mechanism of Zika virus NS2B-NS3 protease with dipeptide inhibitors: Insights from molecular docking and molecular dynamics simulations.
    Ullah S; Ullah F; Rahman W; Ullah A; Haider S; Yueguang C
    PLoS One; 2024; 19(8):e0307902. PubMed ID: 39116118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Zika virus NS2B-NS3 protease and NS5 polymerase inhibitors by structure-based virtual screening of FDA-approved drugs.
    Ezzemani W; Altawalah H; Windisch M; Ouladlahsen A; Saile R; Kettani A; Ezzikouri S
    J Biomol Struct Dyn; 2024 Sep; 42(15):8073-8088. PubMed ID: 37528667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Dynamics of Zika Virus NS2B-NS3 Protease Binding to Dipeptide Inhibitors.
    Li Y; Zhang Z; Phoo WW; Loh YR; Wang W; Liu S; Chen MW; Hung AW; Keller TH; Luo D; Kang C
    Structure; 2017 Aug; 25(8):1242-1250.e3. PubMed ID: 28689970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection.
    Starvaggi J; Previti S; Zappalà M; Ettari R
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition.
    Coronado MA; Eberle RJ; Bleffert N; Feuerstein S; Olivier DS; de Moraes FR; Willbold D; Arni RK
    Antiviral Res; 2018 Dec; 160():118-125. PubMed ID: 30393012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell Infection.
    da Silva Sanches PR; de Campos Faria JCE; Bittar C; Guberovich Olivieri HAS; de Moraes Roso Mesquita NC; Noske GD; de Godoy AS; Oliva G; Rahal P; Cilli EM
    Protein Pept Lett; 2024; 31(7):532-543. PubMed ID: 39039677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermolecular interactions of cn-716 and acyl-KR-aldehyde dipeptide inhibitors against Zika virus.
    Campos DMO; Bezerra KS; Esmaile SC; Fulco UL; Albuquerque EL; Oliveira JIN
    Phys Chem Chem Phys; 2020 Jul; 22(27):15683-15695. PubMed ID: 32618974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
    Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
    J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor.
    Lei J; Hansen G; Nitsche C; Klein CD; Zhang L; Hilgenfeld R
    Science; 2016 Jul; 353(6298):503-5. PubMed ID: 27386922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structural characterization of new macrocyclic inhibitors of the Zika virus NS2B-NS3 protease.
    Huber S; Braun NJ; Schmacke LC; Murra R; Bender D; Hildt E; Heine A; Steinmetzer T
    Arch Pharm (Weinheim); 2024 Sep; 357(9):e2400250. PubMed ID: 38809037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel and potential inhibitors against the dengue virus NS2B/NS3 protease using virtual screening and biomolecular simulations.
    Nasir A; Samad A; Ajmal A; Li P; Islam M; Ullah S; Shah M; Bai Q
    Int J Biol Macromol; 2024 Jun; 272(Pt 1):132855. PubMed ID: 38834129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
    Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
    Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MD simulations reveal alternate conformations of the oxyanion hole in the Zika virus NS2B/NS3 protease.
    Ren J; Lee H; Kotak A; Johnson ME
    Proteins; 2020 Feb; 88(2):345-354. PubMed ID: 31461176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high-throughput cell-based screening method for Zika virus protease inhibitor discovery.
    Anindita PD; Otsuka Y; Lattmann S; Ngo KH; Liew CW; Kang C; Harris RS; Scampavia L; Spicer TP; Luo D
    SLAS Discov; 2024 Jul; 29(5):100164. PubMed ID: 38796112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
    Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
    Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor.
    Li Y; Zhang Z; Phoo WW; Loh YR; Li R; Yang HY; Jansson AE; Hill J; Keller TH; Nacro K; Luo D; Kang C
    Structure; 2018 Apr; 26(4):555-564.e3. PubMed ID: 29526431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.
    Lin WW; Huang YJ; Wang YT; Lin YS; Mazibuko N; Chen CS; Cheng TL; Chang CS; Leu YL; Chen CY; Chuang CH
    Virus Res; 2023 May; 329():199092. PubMed ID: 36965673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential ZIKV NS2B-NS3 protease inhibitors from
    Thirumoorthy G; Tarachand SP; Nagella P; Veerappa Lakshmaiah V
    J Biomol Struct Dyn; 2022; 40(21):11203-11215. PubMed ID: 34319220
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of novel Zika virus NS3 protease inhibitors with different inhibition modes by integrative experimental and computational approaches.
    Andrade MA; Mottin M; Sousa BKP; Barbosa JARG; Dos Santos Azevedo C; Lasse Silva C; Gonçalves de Andrade M; Motta FN; Maulay-Bailly C; Amand S; Santana JM; Horta Andrade C; Grellier P; Bastos IMD
    Biochimie; 2023 Sep; 212():143-152. PubMed ID: 37088408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential Zika virus NS2B-NS3 protease inhibitors via docking, molecular dynamics and consensus scoring-based virtual screening.
    Bowen LR; Li DJ; Nola DT; Anderson MO; Heying M; Groves AT; Eagon S
    J Mol Model; 2019 Jun; 25(7):194. PubMed ID: 31209577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.